Effective health systems facing pandemic crisis: lessons from COVID-19 in Europe for next emergencies
International Journal of Health Governance,
Journal Year:
2024,
Volume and Issue:
29(2), P. 89 - 111
Published: June 4, 2024
Purpose
The
investigation
goal
is
the
analysis
of
relation
between
healthcare
expenditures
and
other
resources,
COVID-19
fatality
rates
among
European
countries
to
design
effective
health
policies
for
crisis
management.
Design/methodology/approach
Research
methodology
based
on
descriptive
statistics
various
parametric
methods,
also
including
a
linear
model
regression
analyze
basic
relationships
variables
under
study.
Findings
Results
show
that
lower
rate
associated
with
higher
levels
expenditure
(%
GDP),
per
capita,
in
preventive
care
hospitals
million
inhabitants,
physicians,
nurses,
hospital
beds
curative
acute
1,000
inhabitants.
Regression
shows
1%
increase
capita
countries,
it
reduces
level
by
0.74%.
In
fact,
many
Eastern
Europe
low
2019
(e.g.,
Bulgaria,
Romania,
Hungary,
Poland,
Latvia,
Slovakia,
Lithuania,
etc.),
they
have
experienced
high
rates.
Instead,
lot
Western
Europe,
such
as
Germany,
Denmark,
Austria,
Netherlands,
had
resilient
systems
face
pandemic
Practical
implications
These
findings
suggest
strategies
systematic
continuous
investments
healthcare,
medical
technologies,
ICT
infrastructures
support
policy
management
future
emergencies
society.
Originality/value
explanation
critical
role
GDP)
robust
bolster
resilience
nations
worldwide
crises.
Language: Английский
Uncovering the underlying causes for the narrowing, stalling, and widening Black–White mortality gap from 2000 to 2022 in the United States
Demographic Research,
Journal Year:
2025,
Volume and Issue:
52, P. 535 - 558
Published: March 24, 2025
Language: Английский
Trust and Health Equity—Lessons from the COVID- 19 Pandemic
Journal of General Internal Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 17, 2025
Language: Английский
Immigrant mortality advantage in the United States during the first year of the COVID-19 pandemic
Demographic Research,
Journal Year:
2024,
Volume and Issue:
50, P. 185 - 204
Published: Jan. 22, 2024
OBJECTIVESTo
investigate
the
mortality
impact
of
COVID-19
pandemic
on
US-born
and
foreignborn
populations
by
race
Hispanic
origin
in
United
States
2020.
METHODSDeath
records
from
National
Center
for
Health
Statistics
population
data
CDC
WONDER
were
used
to
estimate
(1)
age-standardized
all-cause
cause-specific
at
ages
25+,
25-64,
65+
2017-2019
2020
nativity,
race,
origin,
sex;
(2)
changes
between
these
two
periods;
(3)
causespecific
contributions
changes.
RESULTSMortality
increased
relative
all
racial
Hispanic-origin
groups.Adjusting
age,
increases
larger
25+
among
males
(390
deaths
100,000
residents)
females
(189)
than
(223)
(144).The
large
rise
foreign-born
men
(593)
contributed
narrowing
their
advantage
White
men,
426
134.An
increase
both
Black
Black-White
disparities
318
180
females.Although
was
main
driver
residents,
circulatory
diseases
malignant
neoplasms
also
contributed.
CONTRIBUTIONWe
show
that
had
a
greater
counterparts.These
findings
highlight
need
address
underlying
inequalities
unique
challenges
faced
populations.
Language: Английский
Cause-Specific Excess Mortality in the US During the COVID-19 Pandemic
Ekaterina Degtiareva,
No information about this author
Andrea M. Tilstra,
No information about this author
Jonas Schöley
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 6, 2024
ABSTRACT
The
COVID-19
pandemic
was
a
significant
shock
to
United
States
mortality,
and
it
is
important
understand
how
the
impacted
other
causes
of
death.
We
estimated
monthly
excess
mortality
in
US
by
cause
death,
age,
sex,
for
official
deaths
at
ages
15
older.
Data
come
from
CDC
Wonder
Multiple
Cause
Death
database.
used
compositionally
robust
Generalized
Additive
Model
(GAM)
estimate
expected
counts
March
2020-December
2022
eight
death:
accidents,
cardiovascular
diseases,
cancer,
diabetes,
influenza
pneumonia,
substance-related
(drugs
alcohol),
suicide,
residual
(including
related
deaths).
Analyses
were
stratified
sex
15-year
age
groups
15-29
75+.
Excess
calculated
as
observed
minus
deaths.
From
2020
December
2022,
we
1
298
763
total
(95%
CI:
226
542
370
804).
While
there
fewer
than
due
some
like
flu/pneumonia
largest
number
deaths,
excluding
COVID-19,
attributed
diseases
(115
765
95%
98
697
133
783)
substance
use
(86
637
79
273
93
690).
Percent
high
across
all
ages,
while
percent
highest
midlife
ages.
Some
these
likely
undercounted
but
others
may
reflect
indirect
impacts
on
healthcare
utilization
or
longer-term
effects
infections.
SIGNIFICANCE
STATEMENT
increased
directly
also
changed
pattern
States.
cause-specific
present
several
findings.
nearly
1.3
million
2022.
Deaths
suicide
pneumonia
lower
based
previous
trends,
(drug
alcohol)
higher.
Cancer
generally
unchanged.
By
quantifying
both
direct
highlight
areas
on-going
vulnerability
US.
Language: Английский
Erosion of the Latino Health Advantage in the US
JAMA Health Forum,
Journal Year:
2024,
Volume and Issue:
5(10), P. e244041 - e244041
Published: Oct. 3, 2024
This
JAMA
Forum
discusses
the
epidemiological
and
theoretical
explanations
regarding
erosion
of
Latino
health
advantage
in
US
proposes
policies
to
promote
immigrant
health.
Language: Английский
Trends and disparities in deaths among young persons in the US during the COVID-19 pandemic
Lauren M. Rossen,
No information about this author
Adriana Resendez,
No information about this author
Amanda Behdin
No information about this author
et al.
Annals of Epidemiology,
Journal Year:
2024,
Volume and Issue:
91, P. 37 - 43
Published: Feb. 2, 2024
Language: Английский
Subnational contribution to life expectancy and life span variation changes: Evidence from the United States
Demographic Research,
Journal Year:
2024,
Volume and Issue:
50, P. 583 - 624
Published: March 27, 2024
BACKGROUNDThe
US
life
expectancy
has
been
stagnating
in
recent
decades,
and
along
with
this,
the
time
trends
of
span
variation
have
shown
stagnation
even
increases
respect
to
historical
levels.
OBJECTIVEWe
aim
disentangle
contributions
from
subnational
levels
(US
regions)
national
changes
2010-2019
2019-2020.
METHODSA
decomposition
change
disparity
into
contribution
changing
mortality
population
structure
among
regions
is
presented.The
Census
are
Midwest,
Northeast,
South,
West.
RESULTSFrom
2010
2019,
South
substantially
contributed
increase
due
increasing
contributions.The
old-age
survival
improvements
across
all
further
at
level.Different
growth
patterns
regions,
especially
older
ages,
a
source
expectancy.
Language: Английский
Serum‐derived bovine immunoglobulin treatment in COVID‐19 is associated with faster resolution of symptoms: A randomized pilot clinical trial
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(10)
Published: Oct. 1, 2024
Effective
treatment
to
prevent
hospitalization
and
death
in
people
with
COVID-19
exists,
but
still
need
interventions
that
alleviate
symptoms
without
drug
interactions.
Oral
serum-derived
bovine
immunoglobulins
(SBI)
may
reduce
time-to-improvement
mild-to-moderate
COVID-19.
In
this
randomized,
open-label,
single-site
study,
participants
received
SBI
5.0
g
bis
die
(BID)
+
Standard
of
Care
(SOC)
or
SOC
alone
(2:1)
for
2
weeks.
After
weeks,
78.8%
hospitalized
on
improved
by
World
Health
Organization
(WHO)
scale
≥3
compared
61.1%
(odds
ratio:
OR
=
2.4;
p
0.0663),
older
(>57
years)
showing
more
significant
differences
between
the
arms
(OR
6.1;
0.0109).
Further,
reported
absence
at
Week
(74.2%)
(43.6%;
3.7;
0.0031),
most
notably
dyspnea
exertion
4.4;
0.0047),
women
exhibiting
eradication
all
5.8;
0.0080).
No
difference
change
IL-6
was
observed.
Overall,
had
a
shorter
time-to-recovery
than
alone,
significantly
higher
rate
complete
resolution
symptoms.
Dyspnea
symptom
impacted.
For
COVID-19,
oral
could
be
safe
effective
intervention,
devoid
Language: Английский
Intersectionality of sex and race in COVID-19 mortality and vaccination inequities in Massachusetts
BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 29, 2024
Inequities
in
COVID-19
incidence,
morbidity,
and
mortality
between
racial
ethnic
groups
the
United
States
(U.S.)
have
been
documented
since
start
of
pandemic
early
2020.
Similarly,
disparities
by
sex
for
morbidity
emerged,
with
men
dying
at
a
higher
rate
than
women.
Little
research
has
done
to
understand
how
intersection
race
impacts
inequities
Massachusetts
(MA).
This
cross-sectional
study
examined
rates
(February
2020-
May
2023)
vaccination
(December
2020-February
varied
across
MA.
Language: Английский